Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
PKBO Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: August 02, 2024
Report Source: 2023 3rd Quarter Report
Peak Bio Inc. Stock Analysis PKBO
United States Health Care Nano Cap Report: Peak Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company is headquartered in Pleasanton, California. The firm's pipeline includes an antibody-drug-conjugate (ADC) platform that includes novel toxins and linkers coupled with important cancer antibody targets and a Phase 2-ready neutrophil elastase inhibitor for alpha1 anti-trypsin deficiency disorder (AATD). Its clinical stage, phase 2 ready asset, PHP-303 (its lead product candidate), is being investigated for the treatment of AATD, a rare genetic disorder and exploring opportunities with PHP-303 for the treatment of acute respiratory distress syndrome (ARDS). PHP- 303 is an oral, once daily, potent, selective small molecule inhibitor of neutrophil elastase (NE) designed to inhibit the bioactive form of NE. Its proprietary toxin, PH-1 or Thailanstatin (a spliceosome modulator) is being used to generate its first pipeline of novel ADC product candidates.
Read More Peak Bio Inc (PKBO) Chart
Key Statistics of Peak Bio Inc (PKBO)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.02Volume
66.14KP/E Ratio (TTM)
-52 Week Range
Market Cap
520.00KAvg. Volume
17.06KDividend Yield
-Financial Metrics & Statements of Peak Bio Inc (PKBO)
FAQ's for Peak Bio Inc (PKBO)
- According to Musaffa’s Shariah screening methodology, Peak Bio Inc (PKBO) is currently classified as NOT HALAL as of August 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Peak Bio Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Peak Bio Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Peak Bio Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Peak Bio Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Peak Bio Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.